Literature DB >> 17848601

Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands.

J Alex Goodwin1, Edward C Hulme, Christopher J Langmead, Ben G Tehan.   

Abstract

Alanine substitution mutagenesis has been used to investigate residues that make up the roof and floor of the muscarinic binding pocket and regulate ligand access. We mutated the amino acids in the second extracellular loop of the M1 muscarinic acetylcholine receptor that are homologous to the cis-retinal contact residues in rhodopsin, the disulfide-bonded Cys178 and Cys98 that anchor the loop to transmembrane helix 3, the adjoining acidic residue Asp99, and the conserved aromatic residues Phe197 and Trp378 in the transmembrane domain. The effects on ligand binding, kinetics, and receptor function suggest that the second extracellular loop does not provide primary contacts for orthosteric ligands, including acetylcholine, but that it does contribute to microdomains that are important for the conformational changes that accompany receptor activation. Kinetic studies suggest that the disulfide bond between Cys98 and Cys178 may contribute to structures that regulate the access of positively charged ligands such as N-methyl scopolamine to the binding pocket. Asp99 may act as a gatekeeper residue to this channel. In contrast, the bulkier lipophilic ligand 3-quinuclidinyl benzilate may require breathing motions of the receptor to access the binding site. Trp378 is a key residue for receptor activation as well as binding, whereas Phe197 represents the floor of the N-methyl scopolamine binding pocket but does not interact with acetylcholine or 3-quinuclidinyl benzilate. Differences between the binding modes of N-methyl scopolamine, 3-quinuclidinyl benzilate, and acetylcholine have been modeled. Although the head groups of these ligands occupy overlapping volumes within the binding site, their side chains may follow significantly different directions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848601     DOI: 10.1124/mol.107.038265

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

1.  Conformational changes in the M2 muscarinic receptor induced by membrane voltage and agonist binding.

Authors:  Ricardo A Navarro-Polanco; Eloy G Moreno Galindo; Tania Ferrer-Villada; Marcelo Arias; J Ryan Rigby; José A Sánchez-Chapula; Martin Tristani-Firouzi
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

Review 2.  Development of M1 mAChR allosteric and bitopic ligands: prospective therapeutics for the treatment of cognitive deficits.

Authors:  Briana J Davie; Arthur Christopoulos; Peter J Scammells
Journal:  ACS Chem Neurosci       Date:  2013-05-23       Impact factor: 4.418

3.  Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor.

Authors:  Peter Keov; Laura López; Shane M Devine; Celine Valant; J Robert Lane; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

4.  Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.

Authors:  Alaa Abdul-Ridha; Laura López; Peter Keov; David M Thal; Shailesh N Mistry; Patrick M Sexton; J Robert Lane; Meritxell Canals; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

5.  Distinct second extracellular loop structures of the brain cannabinoid CB(1) receptor: implication in ligand binding and receptor function.

Authors:  Joong-Youn Shim; James Rudd; Tomas T Ding
Journal:  Proteins       Date:  2011-02

Review 6.  Understanding functional residues of the cannabinoid CB1.

Authors:  Joong-Youn Shim
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

7.  Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.

Authors:  David M Thal; Bingfa Sun; Dan Feng; Vindhya Nawaratne; Katie Leach; Christian C Felder; Mark G Bures; David A Evans; William I Weis; Priti Bachhawat; Tong Sun Kobilka; Patrick M Sexton; Brian K Kobilka; Arthur Christopoulos
Journal:  Nature       Date:  2016-03-09       Impact factor: 49.962

8.  Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors.

Authors:  Guillaume Lebon; Christopher J Langmead; Ben G Tehan; Edward C Hulme
Journal:  Mol Pharmacol       Date:  2008-11-11       Impact factor: 4.436

9.  Helix 8 of the M1 muscarinic acetylcholine receptor: scanning mutagenesis delineates a G protein recognition site.

Authors:  Robert G Kaye; José W Saldanha; Zhi-Liang Lu; Edward C Hulme
Journal:  Mol Pharmacol       Date:  2011-01-19       Impact factor: 4.436

10.  Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation.

Authors:  Shivani Ahuja; Viktor Hornak; Elsa C Y Yan; Natalie Syrett; Joseph A Goncalves; Amiram Hirshfeld; Martine Ziliox; Thomas P Sakmar; Mordechai Sheves; Philip J Reeves; Steven O Smith; Markus Eilers
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.